The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity

FEBS Letters
A WilmenR Göke

Abstract

The glucagon-like peptide 1 (7-37)/(7-36) amide (GLP-1) receptor belongs to a new subclass of seven transmembrane domain, G-protein coupled receptors comprising several receptors for peptide hormones. The receptors of this family share many common motifs including a relatively large N-terminal extracellular domain. The GLP-1 receptor is presently attracting much attention, since it is the target protein of the antidiabetic gut hormone GLP-1. To establish the functional significance of the N-terminal part of the GLP-1 receptor for ligand binding, the extracellular domain was isolated and purified. Utilizing CHL cells expressing the cloned GLP-1 receptor, we demonstrate that the isolated, solubilized N-terminal part of the receptor protein competes for GLP-1 binding with the intact wild-type receptor. Moreover, in cross-linking experiments radiolabeled GLP-1 was covalently attached to the isolated N-terminus, thereby demonstrating direct physical interaction of both components. By Western blot analysis two specific bands were detectable, representing the N-terminal receptor protein in the presence or absence of bound ligand. These data underline the significance of the N-terminal domain of the GLP-1 receptor for ligand binding.

References

Sep 16, 1992·Biochemical and Biophysical Research Communications·P N GravesT F Davies
Apr 1, 1991·European Journal of Clinical Investigation·R GökeB Göke
Mar 1, 1988·The Journal of Endocrinology·R Göke, J M Conlon
Jun 26, 1995·Biochemical and Biophysical Research Communications·J P VilardagaP Robberecht
Jan 1, 1993·The American Journal of Physiology·J M RenJ O Holloszy

❮ Previous
Next ❯

Citations

Jun 25, 2003·Computational Biology and Chemistry·William R TaylorRobert P Bywater
Jun 5, 2007·Nature Chemical Biology·William W JaRichard W Roberts
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·A P WestP J Bjorkman
May 19, 2009·Trends in Biochemical Sciences·Christoph ParthierMilton T Stubbs
Feb 20, 2007·Pharmacology & Therapeutics·Máire E Doyle, Josephine M Egan
Sep 29, 2011·British Journal of Pharmacology·Dan Donnelly
Sep 15, 2004·Diabetes Research and Clinical Practice·Yoshiharu TokuyamaAzuma Kanatsuka
Jan 30, 2013·Biochemical Society Transactions·Cassandra KoolePatrick M Sexton
Dec 22, 1999·Endocrine Reviews·T J Kieffer, J F Habener
Jan 24, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiaohan SongNan Wang
Nov 10, 2005·Journal of Endocrinological Investigation·C M RotellaE Mannucci
Jul 20, 2007·Biochemical Society Transactions·R MannD Donnelly
Jun 3, 2018·Hormones : International Journal of Endocrinology and Metabolism·Vlasios KarageorgosGeorge Liapakis
Apr 27, 2017·Annals of Pediatric Endocrinology & Metabolism·Seungah Lee, Dong Yun Lee
Nov 27, 2019·Molecular Metabolism·T D MüllerM H Tschöp
Jun 6, 2018·Bioconjugate Chemistry·Andrej BabičNorbert Lange
Dec 15, 2020·ACS Chemical Biology·Chelsea K LongwellJennifer R Cochran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.